Mankind Pharma Ltd vs Panacea Biotec Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Mankind Pharma Ltd is ₹ 2246 as of 30 Apr 15:30 . The P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 50.2 on March 2025 . This represents a CAGR of 2.16% over 2 yearsThe P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 99973 crore on March 2025 . This represents a CAGR of 4.23% over 2 yearsThe Market Cap of Panacea Biotec Ltd changed from ₹ 1086 crore on March 2021 to ₹ 2699 crore on March 2025 . This represents a CAGR of 19.96% over 5 years The revenue of Mankind Pharma Ltd for the Dec '25 is ₹ 3643 crore as compare to the Sep '25 revenue of ₹ 3791 crore. This represent the decline of -3.91% The revenue of Panacea Biotec Ltd for the Dec '25 is ₹ 170.24 crore as compare to the Sep '25 revenue of ₹ 150.23 crore. This represent the growth of 13.32% The ebitda of Mankind Pharma Ltd for the Dec '25 is ₹ 888.8 crore as compare to the Sep '25 ebitda of ₹ 1015 crore. This represent the decline of -12.48% The ebitda of Panacea Biotec Ltd for the Dec '25 is ₹ 16.79 crore as compare to the Sep '25 ebitda of ₹ -8.69 crore. This represent the decline of -293% The net profit of Mankind Pharma Ltd changed from ₹ 543.07 crore to ₹ 413.88 crore over 7 quarters. This represents a CAGR of -14.38% The net profit of Panacea Biotec Ltd changed from ₹ -15.88 crore to ₹ 3.89 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Mankind Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Mankind Pharma Ltd

Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

About Panacea Biotec Ltd

India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Limited.
The name of the Company was changed to the present 'Panacea Biotec Limited' in 1993. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines. The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively.

FAQs for the comparison of Mankind Pharma Ltd and Panacea Biotec Ltd

Which company has a larger market capitalization, Mankind Pharma Ltd or Panacea Biotec Ltd?

Market cap of Mankind Pharma Ltd is 92,743 Cr while Market cap of Panacea Biotec Ltd is 2,214 Cr

What are the key factors driving the stock performance of Mankind Pharma Ltd and Panacea Biotec Ltd?

The stock performance of Mankind Pharma Ltd and Panacea Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mankind Pharma Ltd and Panacea Biotec Ltd?

As of May 3, 2026, the Mankind Pharma Ltd stock price is INR ₹2246.55. On the other hand, Panacea Biotec Ltd stock price is INR ₹361.5.

How do dividend payouts of Mankind Pharma Ltd and Panacea Biotec Ltd compare?

To compare the dividend payouts of Mankind Pharma Ltd and Panacea Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.